Lignin Products Market 2022: Global Industry Trends, Share, Size, Growth and Forecast Till 2027

According to IMARC Group’s latest report, titled “Lignin Products Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027.’ The global lignin products market reached a value of US$ 988 Million in 2021. Lignin products refer to the goods manufactured using complex and organic polymers that occur naturally in the cell walls of dried plants. Some of the commonly used lignin products include high-purity and kraft lignin and lignosulphonates. They exhibit binding properties and are widely used for water treatment, oil well drilling and oil recovery. They are also used as a substitute for fossil-based materials in plastic and chemical products. As a result, lignin products find extensive application in the production of animal feed, plastics, polymers, resins, additives and carbon fibers.



We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report

Request for a PDF sample of this report: https://www.imarcgroup.com/lignin-products-market/requestsample

The global lignin products market is primarily being driven by the increasing demand for surface stabilizers to bind dust particles. Lignosulfonates are widely used on paved roads and construction sites to minimize the release of airborne dust particles. Moreover, various product innovations, such as the launch of biodegradable polymers, bio-asphalts and bio-based carbon fibers, are favoring the market growth. These products are extensively used in the production of plywood, oriented strand board (OSB), laminated veneer lumber (LVL), paper lamination and insulation materials. Other factors, including the increasing utilization of lignin products in pharmaceuticals medicines, along with the widespread product adoption in pesticides and animal feed pellets, are creating a positive outlook for the market. Looking forward, IMARC Group expects the market to reach US$ 1,222 Million by 2027, exhibiting at a CAGR of 3.30% during 2022-2027.

Competitive Landscape:

·         Aditya Birla Management Corporation Pvt. Ltd.

·         Borregaard AS

·         Domtar Corporation

·         Green Agrochem

·         Ingevity Corporation

·         Merck KGaA

·         Nippon Paper Industries Co. Ltd.

·         Rayonier Advanced Materials

·         Stora Enso Oyj

·         The Dallas Group of America Inc.

·         West Fraser Timber Co. Ltd.

·         Wuhan East China Chemical Co. Ltd.

Key Market Segmentation:

Breakup by Product:

·      Organosolv Lignin

·      Kraft Lignin

·      Lignosulphonates

·      Others
 

Breakup by Source:

·      Cellulosic Ethanol

·      Kraft Pulping

·      Sulphite Pulping 

Breakup by Application:

·      Concrete Additive

·      Animal Feed

·      Vanillin

·      Dispersant

·      Resins

·      Activated Carbon

·      Carbon Fibers

·      Plastics/Polymers

·      Phenol and Derivatives

·      Others

Breakup by Region:

·      North America (United States, Canada)

·      Europe (Germany, France, United Kingdom, Italy, Spain, Others)

·      Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)

·      Latin America (Brazil, Mexico, Others)

·      Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Others)

Ask Analyst for Customization and Explore full report with TOC & List of Figures:   https://bit.ly/3ubTgEw

We are updating our reports, If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.

Key highlights of the report:                                                           

  • Market Performance (2016-2021)
  • Market Outlook (2022-2027)
  • Market Trends
  • Market Drivers and Success Factors
  • The Impact of COVID-19 on the Global Market
  • Value Chain Analysis
  • Structure of the Global Market
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us        

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.


Contact Us

IMARC Group

30 N Gould St Ste R

Sheridan, WY 82801 USA - Wyoming

Email: Sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

Americas: - +1 631 791 1145 | Africa and Europe: - +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

 

Comments

Post a Comment

Popular posts from this blog

Outsourcing in Banking: Enhancing Efficiency and Addressing Risks

Image
Outsourcing in the banking sector has become a crucial strategy for streamlining products and services, optimizing resource management, reducing costs, and ultimately delivering greater value to customers. As financial institutions navigate a complex regulatory landscape, they are increasingly focusing on their core activities and looking for ways to enhance operational efficiency. The Need for Cost Optimization Banks face various challenges, including capital requirements, financial reporting, and corporate governance standards. Many institutions have shifted their attention from global capital markets to concentrate on their fundamental banking operations. This shift is essential not only for compliance but also for maintaining competitiveness in a market where operating costs significantly impact the pricing of financial products. To remain competitive, banks must find ways to lower their operational costs without compromising service quality. This is where outsourcing comes into pl...
Read more

North America Frozen Seafood Market: Industry Overview, Growth, Trends, Opportunities and Forecast Till 2026

Image
 According to IMARC Group’s latest report, titled “ North America Frozen Seafood Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026 ”, the North America frozen seafood market reached a value of US$ 13.4 Billion in 2020. Frozen seafood products are preserved for inhibiting the growth of bacteria in order to increase their shelf life, taste, and nutritional value. The seafood freezing technique includes two different approaches, namely, cryofreezing and carboxymethylcellulose. In cryofreezing, seafood items, such as salmon, tuna, shrimp, oysters, and tilapia, are kept in ultra-low liquid nitrogen for maintaining their quality. On the other hand, carboxymethylcellulose is used to curb the adulteration of seafood commodities. We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report. Request for a PDF sample of this report : https...
Read more

Biosimilar Market Size 2022-27: Trends, Share, Growth, Opportunity and Forecast

Image
According to the recent report by IMARC Group, entitled “ Biosimilar Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027 ”, the  global biosimilar market size was estimated to be US$ 13.0 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 60.8 Billion by 2027, exhibiting at a CAGR of 26.1% during 2022-2027. Biosimilars, also known as subsequent entry biologics (SEBs) or follow-on biologics, refer to FDA-approved biotherapeutic products which are similar to their reference biologics. Biosimilars can only be manufactured after the patent of the reference product expires. The demand for biosimilars has been increasing in recent years as they help in reducing the overall cost of the treatment for a variety of chronic diseases including cancers, autoimmune diseases, kidney failure, diabetes, CVDs, haematological disorders, infectious diseases, rheumatoid arthritis, growth hormone deficiency, etc. We are regularly track...
Read more